Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
6
Number of overlapping holdings
20.0%
% of FBT's 31 holdings also in IBRN
15.0%
% of IBRN's 58 holdings also in FBT
Overlap by Weight
Sector Drift (FBT minus IBRN)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FBT |
Weight in IBRN |
Overlap | |
|---|---|---|---|---|
 |
NEUROCRINE BIOSCIENCES INC | 3.7% | 4.5% | 3.7% |
|
BIOGEN IDEC INC | 3.4% | 3.9% | 3.4% |
 |
ARGENX SE ADR | 3.4% | 5.0% | 3.4% |
|
ACADIA PHARMACEUTICALS INC | 3.4% | 4.2% | 3.4% |
 |
ALKERMES PLC | 3.3% | 3.9% | 3.3% |
Position Highlights (Non-Overlapping Exposures)
FBT Overweight Relative to IBRN
 |
GENMAB A/S SPONSORED ADR | 3.5% |
|
REPLIGEN CORP | 3.5% |
|
BIOMARIN PHARMACEUTICAL INC | 3.5% |
|
EXELIXIS INC | 3.4% |
|
INCYTE CORP | 3.4% |
 |
BIONTECH SE SPONSORED ADR | 3.4% |
|
KRYSTAL BIOTECH, INC. | 3.4% |
|
REGENERON PHARMACEUTICALS | 3.4% |
|
UNITED THERAPEUTICS CORP | 3.4% |
|
VERTEX PHARMACEUTICALS INC | 3.4% |
FBT Underweight Relative to IBRN
|
CATALYST PHARMACEUTICAL PART | -5.1% |
 |
SK BIOPHARMACEUTICALS CO., LTD. | -5.0% |
|
PTC THERAPEUTICS INC | -4.5% |
|
SCHOLAR ROCK HOLDING CORP. | -4.3% |
|
SUPERNUS PHARMACEUTICALS INC | -4.2% |
|
DENALI THERAPEUTICS INC. | -3.8% |
|
INTEGRA LIFESCIENCES HOLDING | -2.7% |
|
EDGEWISE THERAPEUTICS, INC. | -2.3% |
 |
SANBIO CO., LTD. | -2.1% |
|
ANAVEX LIFE SCIENCES CORP. | -1.9% |